Colson P, Ribstein J, Chaptal P A, Mimran A, Roquefeuil B
Anesthésie-réanimation B, CHU, Montpellier.
Arch Mal Coeur Vaiss. 1990 Jul;83(8):1123-5.
Medical preparation for pheochromocytoma surgery requires adrenergic blockade and restoration of euvolemia. Usually, this preoperative preparation consisted essentially of sequential and progressive adrenergic antagonism, alpha then beta blockade. This therapy is not easy to introduce and exposes to blood pressure collapses after tumor removal. By contrast, calcium channel blocking drugs like dihydropyridines offer efficacy and safety. Moreover, new intravenous (IV) agents (nicardipine, diltiazem) provide useful therapeutic tools to control, rapidly and with a dose-dependent effect, any undesired hemodynamic event during surgery. As a demonstration of this new therapeutic strategy for management of pheochromocytoma resection, we report here the cases of two patients who were exclusively treated with dihydropyridines. A 61 year-old woman and a 41 year-old man were scheduled for pheochromocytoma resection (left and right adrenal tumors, respectively). Both patients received dihydropyridines for preoperative preparation (nicardipine and nifedipine, respectively, 60 mg/day). This treatment allowed a good control of arterial blood pressure (BP) (from 210/110 to 170/90 and 180/100 to 140/80 mmHg, respectively) and was maintained up to the morning of the operative day. After patient installation on the operating-table, IV nicardipine infusion was started (2 mg/hour). Anesthesia consisted of high doses of fentanyl, flunitrazepam and vecuronium. Hemodynamic measurements (radial artery and Swan ganz catheters) allowed adjustment of nicardipine infusion rate to maintain peripheral arterial resistances under 1,000 dynes.s.cm-5, and adequate volume loading. A hypertensive crisis (270/130 mmHg) occurred at the time of the intubation in the first case but responded to higher infusion rate of nicardipine (5 mg/10 min).(ABSTRACT TRUNCATED AT 250 WORDS)
嗜铬细胞瘤手术的医学准备需要进行肾上腺素能阻断并恢复血容量正常。通常,这种术前准备主要包括序贯性和渐进性的肾上腺素能拮抗,即先进行α阻断,然后进行β阻断。这种疗法引入并不容易,且在肿瘤切除后有血压骤降的风险。相比之下,像二氢吡啶类这样的钙通道阻滞剂具有疗效和安全性。此外,新型静脉用药(尼卡地平、地尔硫䓬)为控制手术期间任何不良血流动力学事件提供了有用的治疗工具,能快速且呈剂量依赖性地发挥作用。作为这种嗜铬细胞瘤切除术新治疗策略的例证,我们在此报告两名仅接受二氢吡啶类药物治疗的患者病例。一名61岁女性和一名41岁男性计划接受嗜铬细胞瘤切除术(分别为左侧和右侧肾上腺肿瘤)。两名患者均接受二氢吡啶类药物进行术前准备(分别为尼卡地平和平硝苯地平,60毫克/天)。这种治疗使动脉血压得到良好控制(分别从210/110降至170/90以及从180/100降至140/80毫米汞柱),并维持到手术当天早晨。患者安置在手术台上后,开始静脉输注尼卡地平(2毫克/小时)。麻醉采用高剂量芬太尼、氟硝西泮和维库溴铵。血流动力学测量(桡动脉和Swan - ganz导管)可调整尼卡地平输注速率,以维持外周动脉阻力低于1000达因·秒·厘米⁻⁵,并进行适当的容量负荷补充。第一例患者在插管时发生高血压危象(270/130毫米汞柱),但通过提高尼卡地平输注速率(5毫克/10分钟)得到缓解。(摘要截选至250字)